These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 9496339

  • 1. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
    Dunson TR, Blumenthal PD, Alvarez F, Brache V, Cochon L, Dalberth B, Glover L, Remsburg R, Vu K, Katz D.
    Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
    [Abstract] [Full Text] [Related]

  • 2. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus.
    Petta CA, Faundes A, Dunson TR, Ramos M, DeLucio M, Faundes D, Bahamondes L.
    Fertil Steril; 1998 Feb; 69(2):252-7. PubMed ID: 9496338
    [Abstract] [Full Text] [Related]

  • 3. Temporal relationship between Uniplant insertion and changes in cervical mucus.
    Barbosa IC, Coutinho E, Hirsch C, Ladipo OA, Olsson SE, Ulmsten U.
    Contraception; 1996 Oct; 54(4):213-7. PubMed ID: 8922874
    [Abstract] [Full Text] [Related]

  • 4. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
    Sivin I, Lähteenmäki P, Mishell DR, Alvarez F, Diaz S, Ranta S, Grozinger C, Lacarra M, Brache V, Pavez M, Nash H, Stern J.
    Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
    [Abstract] [Full Text] [Related]

  • 5. Effect of preovulatory insertion of Norplant implants over luteinizing hormone secretion and follicular development.
    Brache V, Alvarez F, Faundes A, Cochon L, Thevenin F.
    Fertil Steril; 1996 Jun; 65(6):1110-4. PubMed ID: 8641481
    [Abstract] [Full Text] [Related]

  • 6. Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants.
    Alvarez F, Brache V, Tejada AS, Cochon L, Faundes A.
    Contraception; 1998 Oct; 58(4):211-4. PubMed ID: 9866001
    [Abstract] [Full Text] [Related]

  • 7. Treatment with Norplant subdermal implants inhibits sperm penetration through cervical mucus in vitro.
    Croxatto HB, Díaz S, Salvatierra AM, Morales P, Ebensperger C, Brandeis A.
    Contraception; 1987 Aug; 36(2):193-201. PubMed ID: 3123133
    [Abstract] [Full Text] [Related]

  • 8. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A, Brache V, Tejada AS, Cochon L, Alvarez-Sanchez F.
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [Abstract] [Full Text] [Related]

  • 9. Levonorgestrel implant use among adolescents.
    Mashburn M.
    J Pediatr Health Care; 1994 Jul; 8(6):255-60. PubMed ID: 7799199
    [Abstract] [Full Text] [Related]

  • 10. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [Abstract] [Full Text] [Related]

  • 11. Endometrial angiogenic response in Norplant users.
    Subakir SB, Hadisaputra W, Handoyo AE, Affandi B.
    Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
    [Abstract] [Full Text] [Related]

  • 12. NORPLANT contraceptive implants advancing.
    Segal SJ.
    Netw Res Triangle Park N C; 1984 Oct; 5(3):1-3. PubMed ID: 12279797
    [Abstract] [Full Text] [Related]

  • 13. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.
    Barbosa I, Coutinho E, Hirsch C, Ladipo O, Olsson SE, Ulmsten U.
    Fertil Steril; 1996 Apr; 65(4):724-9. PubMed ID: 8654629
    [Abstract] [Full Text] [Related]

  • 14. Norplant implants: the mechanism of contraceptive action.
    Segal SJ, Alvarez-Sanchez F, Brache V, Faundes A, Vilja P, Tuohimaa P.
    Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
    [Abstract] [Full Text] [Related]

  • 15. Ultrasonographic and endocrine evaluation of ovarian function among Norplant implants users with regular menses.
    Alvarez F, Brache V, Faundes A, Tejada AS, Thevenin F.
    Contraception; 1996 Nov; 54(5):275-9. PubMed ID: 8934060
    [Abstract] [Full Text] [Related]

  • 16. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
    Darney PD, Taylor RN, Klaisle C, Bottles K, Zaloudek C.
    Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486
    [Abstract] [Full Text] [Related]

  • 17. Preliminary experience with Norplant in an inner city population.
    Cullins VE, Blumenthal PD, Remsburg RE, Huggins GR.
    Contraception; 1993 Feb; 47(2):193-203. PubMed ID: 8449019
    [Abstract] [Full Text] [Related]

  • 18. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR, Morehead DB, Baldwin DM, Castracane VD, Lasley B, Bergquist CA.
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of enlarged ovarian follicles among users of levonorgestrel subdermal contraceptive implants (Norplant).
    Alvarez-Sanchez F, Brache V, de Oca VM, Cochon L, Faúndes A.
    Am J Obstet Gynecol; 2000 Mar; 182(3):535-9. PubMed ID: 10739504
    [Abstract] [Full Text] [Related]

  • 20. New concepts in contraception: Norplant subdermal implant.
    Lynn MM, Holdcroft C.
    Nurse Pract; 1992 Mar; 17(3):85-9. PubMed ID: 1565306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.